Expanding Horizons: From CEE to entire Europe
To improve patient recruitment, engagement and retention for Sponsors wanting to conduct clinical trials in any European country, Research Professionals DCT (RP-DCT) has expanded its geographical coverage to cover these entire regions. With home visits by qualified nurses and accompanying DCT technology, this expansion broadens the potential pool of trial participants for Sponsors and brings advanced clinical research directly to patients’ homes.

The greatest challenge in clinical research has always been patient recruitment and retention and it costs sponsors huge sums of money opening new sites and lengthening study durations. RP-DCT has been acutely aware of this since its inception in 2014 and can now help biotech, pharma, medtech and other CROs to shorten timelines and adhere to budgets. It also makes clinical trials more accessible for patients, enriches the diversity of the participant population and enhances the generalizability of the trial results.

Comprehensive Quality Management System (QMS)
As RP-DCT scales its operations to accommodate an increasing number of decentralized trials, it has upgraded its Quality Management System (QMS) to handle the upscaled volume of research nurses and clinical activities. The enhanced QMS ensures that all clinical trials are conducted in compliance with Good Clinical Practice (GCP) standards, maintaining the highest levels of data integrity and patient safety. This meticulous approach to quality management allows RP-DCT to deliver consistent and reliable results across all its trials, regardless of their complexity or geographical scope.

Digital Platform for Seamless Trial Management
In addition to its extensive geographical coverage and rigorous QMS, RP-DCT can offer a sophisticated digital platform designed to streamline every aspect of clinical trial management. This platform supports pre-screening and recruitment, sends reminders to patients to take their medication, provides ePRO questionnaires, integrates connected devices including wearables, and provides role-specific information to enhance user experience. Our digital service is accessible via laptop and mobile devices, with offline options available for synchronization, ensuring uninterrupted access to critical data. This application is fully compliant with GDPR, HIPAA, and 21 CFR Part 11, ensuring that all data is managed securely and ethically. The platform features modular software tailored to all aspects of clinical trial management.

Improved Patient Engagement and Retention
By bringing the clinical trial to the patient’s home, RP-DCT minimizes the inconvenience and disruption often associated with trial participation. This patient-centric approach fosters a sense of trust and reliability, encouraging patients to remain in the trial until its conclusion. The personalized attention provided by RP-DCT’s highly trained research nurses ensures that patients feel valued and supported throughout the trial, further enhancing their commitment.

Tailored Decentralized Services
RP-DCT offers a comprehensive suite of services designed to support decentralized clinical trials from start to finish. These services include the design of source documentation for DCT activities, study-specific and general training for research nurses, and the management of off-site visits and home care nursing activities. By providing study visit-required equipment or materials directly to research nurses, RP-DCT ensures that all necessary resources are available for the smooth conduct of the trial.

Expertise in Therapeutic Areas and Rare Diseases
RP-DCT has conducted over 60 decentralized trials across a wide range of therapeutic areas, including autoimmune diseases, cardiovascular disorders, dermatology, gastroenterology, hematology, nephrology, obstetrics/gynecology, oncology, ophthalmology, psychiatry/psychology, and pulmonary/respiratory diseases. In addition to these common therapeutic areas, RP-DCT has also completed studies in rare disease indications such as Duchenne muscular dystrophy, familial chylomicronemia syndrome (FCS), generalized myasthenia gravis, idiopathic inflammatory myopathy, late-onset Pompe disease, and acromegaly.

Partner with RP-DCT
If you are looking to enhance your clinical trial operations and leverage the benefits of decentralized trials, RP-DCT is your ideal partner. With extensive experience, a broad geographical reach, and a commitment to quality and patient-centricity, RP-DCT can help you achieve your clinical research goals. Contact us today to schedule an introductory call and learn more about our capabilities and extensive decentralized trial experience.

Contact Information

• Website: https://rp-dct.com
• Email: contact@rp-dct.com
• Phone: +36 20 777 4761

Partner with Research Professionals DCT and experience the future of clinical trials today.Partner with Research Professionals DCT and experience the future of clinical trials today.

Case Studies and Resources
For a deeper insight into the advantages of decentralized clinical trials and how RP-DCT has successfully implemented them, we invite you to explore our case studies and resources:

• Integrated Clinical and Decentralized Approach to Accelerate Clinical Trials: Discover how our integrated approach has accelerated clinical trials and improved patient outcomes. Read more
  
  
• Speed and Flexibility Delivered Through Decentralized Clinical Trials (DCTs): Learn about the speed and flexibility advantages of DCTs and how they have benefited our clients. Read more

RP-DCT is committed to advancing the field of clinical research through innovative, patient-centric approaches. Join us in revolutionizing clinical trials and improving patient outcomes worldwide.